Elahere 100 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,736
Award facts
- Contract value 100% obligated
- $41,735.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Elahere (mirvetuximab soravtansine) 100 mg/20 ml vials, with a contract ceiling value of $41,735.60 and an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract constitutes a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support contract.
Elahere is a specialized oncology therapeutic used in the treatment of certain ovarian cancer types, reflecting AmerisourceBergen Drug Corp's critical role as a primary pharmaceutical distributor supporting military and federal healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. This award exemplifies the Defense Logistics Agency's reliance on established pharmaceutical prime vendors to ensure reliable access to specialized medical products for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9DZ1?
SPE2DR26F9DZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9DZ1 worth?
The government has obligated $41,736 on SPE2DR26F9DZ1.
Is contract SPE2DR26F9DZ1 an order under another contract?
Yes. SPE2DR26F9DZ1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DZ1 competed?
The extent of competition for SPE2DR26F9DZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award